Ampio Pharmaceuticals

(OTC) AMPE

Current Price$0.18

Market Cap$207,900

Since IPO (2010)-100%

5 YearN/A

1 Year+6,003%

1 Month-15%

Ampio Pharmaceuticals Financials at a Glance

Market Cap

$207,900

Revenue (TTM)

$245.00K

Net Income (TTM)

$8.63M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.18

Volume

Open

$0.18

Price

$0.18

Volume

Open

$0.18

Previous Close

$0.18

Daily Range

$0.18 - $0.18

52-Week Range

$0.00 - $0.64

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.18

Volume

Open

$0.18

Previous Close

$0.18

Daily Range

$0.18 - $0.18

52-Week Range

$0.00 - $0.64

AMPE News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ampio Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Michael A. Martino, MBA

Website

www.ampiopharma.com

Headquarters

Englewood, CO 80112, US

AMPE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$207.90K

Shares Outstanding

1.14M

Volume

Avg. Volume

443.413

Financials (TTM)

Gross Profit

$250.00K

Operating Income

$9.52M

EBITDA

$8.38M

Operating Cash Flow

$8.56M

Capital Expenditure

$0.00

Free Cash Flow

$8.56M

Cash & ST Invst.

$4.09M

Total Debt

$274.00K

Ampio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2023YOY CHG

Revenue

$245.00K

N/A

Gross Profit

$245.00K

+166.4%

Gross Margin

100.00%

N/A

Market Cap

$207.90K

N/A

Market Cap/Employee

$34.65K

N/A

Employees

N/A

Net Income

$2.05M

+2.4%

EBITDA

$2.21M

+12.0%

Quarterly Fundamentals

Name

Q4 2023YOY CHG

Net Cash

$3.81M

-67.8%

Accounts Receivable

$920.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$274.00K

-48.2%

Return on Assets

-1.50%

N/A

Return on Invested Capital

-2.83%

N/A

Free Cash Flow

$2.31M

+46.2%

Operating Cash Flow

$2.31M

+46.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARNIArno Therapeutics, Inc.

ARNIArno Therapeutics, Inc.$0.00+0.00%

STABStatera Biopharma, Inc.

STABStatera Biopharma, Inc.$0.00+0.00%

BTTXBetter Therapeutics, Inc.

BTTXBetter Therapeutics, Inc.$0.00+0.00%

PANCPanacos Pharmaceuticals, Inc.

PANCPanacos Pharmaceuticals, Inc.$0.00+0.00%

IVBTInnovation1 Biotech Inc.

IVBTInnovation1 Biotech Inc.$0.00+0.00%

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

KLDOKaleido Biosciences, Inc.

KLDOKaleido Biosciences, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

INTCIntel

INTCIntel$108.77-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$19.87-0.10%

Questions About AMPE

What is the current price of Ampio Pharmaceuticals?

Ampio Pharmaceuticals is trading at $0.18 per share.

What is the 52-week range for Ampio Pharmaceuticals?

Over the past 52 weeks, Ampio Pharmaceuticals has traded between $0.00 and $0.64.

How much debt does Ampio Pharmaceuticals have?

As of the most recent reporting period, Ampio Pharmaceuticals reported total debt of $274,000.

How much cash does Ampio Pharmaceuticals have on hand?

Ampio Pharmaceuticals reported $4.09M in cash and cash equivalents in its most recent financial results.

What is Ampio Pharmaceuticals’s dividend yield?

Ampio Pharmaceuticals does not currently have a dividend yield.

Ampio Pharmaceuticals

Ampio Pharmaceuticals Financials at a Glance

AMPE News

Here's Why Ampio Pharmaceuticals Stock Is Surging Today

Why Ampio Pharmaceuticals Stock Is Jumping Today

Why Ampio Pharmaceuticals Stock Tanked Today

Here's Why Ampio Pharmaceuticals Inc. Became a Penny Stock Today

Here's Why Ampio Pharmaceuticals Dropped as Much as 18.8% Today

Here's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today

Why Ampio Pharmaceuticals Rose as Much as 15% Today

5 of Last Week's Biggest Winners

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ampio Pharmaceuticals

AMPE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ampio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AMPE

What is the current price of Ampio Pharmaceuticals?

What is the 52-week range for Ampio Pharmaceuticals?

How much debt does Ampio Pharmaceuticals have?

How much cash does Ampio Pharmaceuticals have on hand?

What is Ampio Pharmaceuticals’s dividend yield?

Premium Investing Services